EUVIMEDEUVIMED entdecken
Leserbrief

Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”

Lijun Ge, Yu Xu, Jinfang Yan

Clinical and Molecular Hepatology · 20.08.2026

DOI: 10.3350/cmh.2026.0761 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 20.08.2026. Verfasst von Lijun Ge und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China, 661199.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Pharmacy, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China, 661199.
  • Lijun Ge and Yu Xu equally contributed to the study.
  • Department of Pharmacy, Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State), Yunnan, China, 661199. ly2120303@163.com.

Zitieren

APA

Ge, L., Xu, Y., & Yan, J. (2026). Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0761

Vancouver

Ge L, Xu Y, Yan J. Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0761

BibTeX
@article{Ge2026,
  author = {Ge, Lijun and Xu, Yu and Yan, Jinfang},
  title = {Letter regarding “Lack of Association Between Rifaximin and Drug-resistant Infections: A global multicenter inpatient cirrhosis cohort”},
  journal = {Clinical and Molecular Hepatology},
  year = {2026},
  doi = {10.3350/cmh.2026.0761}
}
Kostenlos starten →